You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics
|
|---|---|
| Published in |
BMC Infectious Diseases, November 2011
|
| DOI | 10.1186/1471-2334-11-315 |
| Pubmed ID | |
| Authors |
Alain H Litwin, Karina M Berg, Xuan Li, Jennifer Hidalgo, Julia H Arnsten |
| Abstract |
Most methadone-maintained injection drug users (IDUs) have been infected with hepatitis C virus (HCV), but few initiate HCV treatment. Physicians may be reluctant to treat HCV in IDUs because of concerns about treatment adherence, psychiatric comorbidity, or ongoing drug use. Optimal HCV management approaches for IDUs remain unknown. We are conducting a randomized controlled trial in a network of nine methadone clinics with onsite HCV care to determine whether modified directly observed therapy (mDOT), compared to treatment as usual (TAU), improves adherence and virologic outcomes among opioid users. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 5 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 89 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 11 | 12% |
| Researcher | 10 | 11% |
| Student > Ph. D. Student | 8 | 9% |
| Student > Bachelor | 8 | 9% |
| Other | 6 | 7% |
| Other | 20 | 22% |
| Unknown | 26 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 29 | 33% |
| Nursing and Health Professions | 12 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
| Psychology | 5 | 6% |
| Immunology and Microbiology | 3 | 3% |
| Other | 11 | 12% |
| Unknown | 24 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2011.
All research outputs
#12,658,011
of 22,656,971 outputs
Outputs from BMC Infectious Diseases
#2,872
of 7,630 outputs
Outputs of similar age
#83,348
of 141,888 outputs
Outputs of similar age from BMC Infectious Diseases
#35
of 92 outputs
Altmetric has tracked 22,656,971 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,630 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 141,888 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 92 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.